Search

everythinglearnresearchcommunity

for

Search:↓

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Some common medications can lower PSA levels in 45-year-old German men.

5-ARI therapy may help prevent prostate cancer progression.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Gene variation affects prostate issues and hair loss.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Hair loss can be an early sign of prostate enlargement.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Sapium rotundifolium extract may help treat enlarged prostate.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

The normal human prostate does not significantly affect blood DHT levels.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Preoperative finasteride can help prevent and reduce transurethral resection syndrome.